美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Synergy Pharmaceuticals

0.0300

0.0000

成交量：- -

成交额：- -

市值：744.11万

市盈率：-0.05

高：0.0300

开：0.0300

低：0.0300

收：0.0300

52周最高：2.24

52周最低：0.0300

股本：2.48亿

流通股本：2.47亿

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.5617

每股收益(LYR):-0.9951

净资产收益率：--

总资产收益率：--

市净率：-0.08

市盈率(LYR):-0.03

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Synergy Pharmaceuticals

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.synergypharma.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Synergy Pharmaceuticals Inc.于2005年11月15日在佛罗里达州注册成立，是一家生物制药公司，主要集中于药物来治疗胃肠道的障碍和疾病的发展。公司主导候选产品是首款治疗女性慢性便秘口服药（plecanatide），一个一种鸟苷酸环化酶C(GC-C)受体激动剂，用于治疗胃肠道疾病，主要是慢性特发性便秘，或慢性特发性便秘和便秘型肠易激综合征，或肠易激综合征-C。慢性特发性便秘和肠易激综合征-C是折磨全世界数百万患者的功能性胃肠病。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SGYP/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SGYP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGYP\",,,,,undefined,":{"symbol":"SGYP","market":"US","secType":"STK","nameCN":"Synergy Pharmaceuticals","latestPrice":0.03,"timestamp":1552680000000,"preClose":0.03,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":247204738,"shares":248037301,"eps":-0.561684,"marketStatus":"盘后交易","change":0,"latestTime":"03-17 17:39:42 EDT","open":0.03,"high":0.03,"low":0.03,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.561684,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773792000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.03,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGYP\",,,,,undefined,":{"symbol":"SGYP","floatShares":247204738,"roa":"--","roe":"--","lyrEps":-0.995115,"shares":248037301,"dividePrice":0,"high":0.03,"amplitude":0,"preClose":0.03,"low":0.03,"week52Low":0.03,"pbRate":"-0.08","week52High":2.235,"institutionHeld":0,"latestPrice":0.03,"eps":-0.561684,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.561684,"open":0.03,"prevYearClose":0.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGYP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"SGYP","fiscalQuarterEnding":"2018/09","expectedEps":-0.13,"name":null,"time":"盘后","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2018-08-07","symbol":"SGYP","fiscalQuarterEnding":"2018/06","expectedEps":-0.17,"name":null,"time":"","type":"earning","dateTimestamp":1533614400000,"reportTimeType":"","actualEps":-0.12},{"market":"US","date":"2018-05-10","symbol":"SGYP","fiscalQuarterEnding":"2018/03","expectedEps":-0.17,"name":null,"time":"盘后","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2018-03-01","symbol":"SGYP","fiscalQuarterEnding":"2017/12","expectedEps":-0.19,"name":null,"time":"盘后","type":"earning","dateTimestamp":1519880400000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2017-11-09","symbol":"SGYP","fiscalQuarterEnding":"2017/09","expectedEps":-0.27,"name":null,"time":"盘后","type":"earning","dateTimestamp":1510203600000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGYP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGYP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.synergypharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0136},{"period":"1month","weight":-0.0187},{"period":"3month","weight":-0.0145},{"period":"6month","weight":0.0149},{"period":"1year","weight":0.1887},{"period":"ytd","weight":-0.0189}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Synergy Pharmaceuticals Inc.于2005年11月15日在佛罗里达州注册成立，是一家生物制药公司，主要集中于药物来治疗胃肠道的障碍和疾病的发展。公司主导候选产品是首款治疗女性慢性便秘口服药（plecanatide），一个一种鸟苷酸环化酶C(GC-C)受体激动剂，用于治疗胃肠道疾病，主要是慢性特发性便秘，或慢性特发性便秘和便秘型肠易激综合征，或肠易激综合征-C。慢性特发性便秘和肠易激综合征-C是折磨全世界数百万患者的功能性胃肠病。","exchange":"NASDAQ","name":"Synergy Pharmaceuticals","nameEN":"Synergy Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SGYP\",market:\"US\",,,undefined,":null}}